Claritev (CTEV) Bank of America Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Bank of America Global Healthcare Conference 2026 summary
14 May, 2026Strategic vision and business outlook
Focus on healthcare impact with 3,000 associates and a strong, mission-driven culture set the foundation for 2024 and beyond.
Core business is described as sticky, with Claims Intelligence up 8.4% year-over-year in Q1 and stable out-of-network market.
Network business is a strategic asset, with aggressive expansion into the TPA space and medium-to-long-term growth expected in Payment and Revenue Integrity.
Provider and public sector verticals are being developed, including pilots in the UAE and U.S., and a significant contract for World Trade Center first responders.
Revenue targets set at $1.1B by 2028 and $1.3B by 2030, with EBITDA goals of $675M and $800M, respectively, and expectations for strong free cash flow yields.
Sales performance and pipeline development
Q1 saw record bookings of $44.1M, with a 70/30 split between organic growth and net new clients, and 36 new logos added in the last five to six quarters.
Sales infrastructure has been strengthened with new leadership and vertical alignment, supporting end-to-end client management.
Gross Revenue Retention remains high at 93%-95%, and the pipeline has expanded to support $100M in annual bookings.
Public sector and provider opportunities are both being pursued, with the World Trade Center contract contributing $5M in ACV.
Sales cycle from booking to revenue conversion is typically 6-12 months, depending on deal type.
Technology, innovation, and client relationships
AI is leveraged for product development, with 53% of code generated by AI in Q1, and is seen as an offensive opportunity.
Deep, long-term client relationships, data rights, and workflow integration are key differentiators against AI-driven competition.
NSA product leadership is highlighted, with ongoing automation and a published product roadmap through 2026.
Clients are engaged through transparent communication, regular business reviews, and dedicated sales representatives.
Investments in technology modernization are expected to drive capital efficiency and support future growth.
Latest events from Claritev
- Transformation drives growth, margin strength, and leadership in healthcare claims innovation.CTEV
Canaccord Genuity's 46th Annual Growth Conference - Q2 2026 revenue up 6.6%, guidance raised, but legal and IT risks remain.CTEV
Q2 2026 - Q1 2026 revenue grew 5.8% to $244.7M, with margin gains but continued net losses.CTEV
Q1 2026 - All proposals, including director elections and plan amendments, were approved without contest.CTEV
AGM 2026 - 2026 guidance targets $980M–$1B revenue, 61–62% EBITDA margin, and AI-driven growth.CTEV
Investor Day 2026 - Transformation and innovation drive growth, profitability, and expanded market reach.CTEV
44th Annual J.P. Morgan Healthcare Conference - Six new market segments, tech innovation, and a $200M pipeline drive growth into 2026.CTEV
BofA Securities Leveraged Finance Conference 2025 - Q1 2025 revenue was $231.3M, net loss narrowed, and transformation advanced.CTEV
Q1 2025 - 2024 net loss surged on a $1.49B impairment as transformation and rebranding drive long-term optimism.CTEV
Q4 2024